p 37

CP 376395 (CP-316311)是一种 CRF1受体选择性拮抗剂。

CAP 37 (20-44)是基于CAP37氨基酸残基20-44的肽，属于37 kDa阳离子抗菌蛋白，具有多功能性。

CGP 37849 是一种竞争性口服活性 N-甲基-D-天冬氨酸 (NMDA) 受体拮抗剂（(Ki = 35 nM)），具有有效性。CGP 37849 是啮齿动物的抗惊厥药，也具有抗抑郁和抗焦虑的特性。

CP 375 is a Fe3+ chelating agent (log K1: 14.50).

Ursolic acid (Prunol) 属于天然产物，是一种五环三萜羧酸，提取自毛喉杜鹃。Ursolic acid 具有抗肿瘤、抗炎、抗菌、降血糖等活性。

TGP-377 421 (Targapre-miR-377 421) 是一种有效的 miR-377 和 miR-421 双重抑制剂，通过与它们的功能位点结合从而能抑制miR-377 和 miR-421发挥作用。

CEP-37440 是一种新型的 FAK (IC50:2.3 nM) 和 ALK (IC50:120 nM) 双重抑制剂。

Tyrosinase (369-377,YMDGTMSQV) is derived from the membrane protein tyrosinase by posttranslational conversion of the sequence YMNGTMSQV. Presentation of YMDGTMSQV in cells expressing full-length tyrosinase is TAP-(transporter associated with antigen proc

CP 376395 hydrochloride is a potent and selective CRF-RI receptor antagonist.

(Asp37)-Amyloid β-Protein (1-42) 是野生型 Amyloid-beta (1-42) 肽的 G37D 突变体。

CSLP37 是一种选择性RIPK2抑制剂，具有16.3 nM的IC50值。它对RIPK1和RIPK3无抑制作用，并且对细胞中的NOD1和NOD2反应表现出强效抑制。

CGP37157 (7-Chloro-5-(2-chlorophenyl)-1,5-dihydro-4,1-benzothiazepine-2(3H)-one) 是一种 Na+ Ca2+ 交换抑制剂，抑制 Na+ 诱导的豚鼠心脏线粒体中 Ca2+ 的释放，IC50 为 0.8 μM。

Anti-CEACAM7 Antibody (P3-7B) 为小鼠IgG1, κ 类型嵌合抗体，专门针对CEACAM7(人源)。该抗体的同型对照是 MouseIgG1kappa, Isotype Control。

FD223 is a potent and selective phosphoinositide 3-kinase delta (PI3Kδ) inhibitor. FD223 displays high potency (IC50=1 nM) and good selectivity over other isoforms (IC50s of 51 nM, 29 nM and 37 nM, respectively for α, β and γ). FD223 exhibits efficient inhibition of the proliferation of acute myeloid leukemia (AML) cell lines by suppressing p-AKT Ser473 thus causing G1 phase arrest during the cell cycle. FD223 has potential for the research of leukemia such as AML[1].

OP-145是一种合成抗菌肽及抗菌肽LL-37的衍生物。它对E. coli、P. aeruginosa、C. albicans和A. niger具有活性（MICs分别为2、3、6和18 µM）。含有OP-145的聚乳酸-共-聚乙二醇酸（PLGA）微球能够在骨折部位接种细菌后通过外科股骨骨折所诱导的小鼠骨感染模型中防止生物膜的形成。

β-Defensin-2 is a peptide with antimicrobial properties that protects the skin and mucosal membranes of the respiratory, genitourinary, and gastrointestinal tracts.1It inhibits the growth of periodontopathogenic and cariogenic bacteria, includingP. gingivalisandS. salivarius.2β-Defensin-2 (30 μg/ml) stimulates gene expression and production of IL-6, IL-10, CXCL10, CCL2, MIP-3α, and RANTES by keratinocytes.3It also stimulates calcium mobilization, migration, and proliferation of keratinocytes when used at concentrations of 30, 10, and 40 μg/ml, respectively. β-Defensin-2 induces IL-31 production by human peripheral blood-derived mast cellsin vitrowhen used at a concentration of 10 μg/ml and by rat mast cellsin vivofollowing a 500 ng intradermal dose.4Expression of β-defensin-2 is increased in psoriatic skin and chronic wounds.5,6 1.Lehrer, R.I.Primate defensinsNat. Rev. Microbiol.2(9)727-738(2004) 2.Ouhara, K., Komatsuzawa, H., Yamada, S., et al.Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, β-defensins and LL37, produced by human epithelial cellsJ. Antimicrob. Chemother.55(6)888-896(2005) 3.Niyonsaba, F., Ushio, H., Nakano, N., et al.Antimicrobial peptides human β-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokinesJ. Invest. Dermatol.127(3)594-604(2007) 4.Niyonsaba, F., Ushio, H., Hara, M., et al.Antimicrobial peptides human β-defensins and cathelicidin LL-37 induce the secretion of a pruritogenic cytokine IL-31 by human mast cellsJ. Immunol.184(7)3526-3534(2010) 5.Huh, W.-K., Oono, T., Shirafuji, Y., et al.Dynamic alteration of human β-defensin 2 localization from cytoplasm to intercellular space in psoriatic skinJ. Mol. Med. (Berl.)80(10)678-684(2002) 6.Butmarc, J., Yufit, T., Carson, P., et al.Human β-defensin-2 expression is increased in chronic woundsWound Repair Regen.12(4)439-443(2004)

HDAC6-IN-37（compound W5）是HDAC6的抑制剂，具有神经保护作用。HDAC6-IN-37可恢复海马神经元形态，减少AD大鼠海马中Aβ、Tau、p-Tau蛋白的表达，抑制老年斑和神经原纤维缠结的形成。因此，HDAC6-IN-37能够改善Aβ Cu2+诱导的AD大鼠模型，调节氧化应激状态，并平衡脑组织中的神经递质紊乱。

P-gp modulator 3 (Compound 37) 是有效的、竞争性的、变构性 P-glycoprotein (P-gp) 调节剂。